Steward Partners Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History

Steward Partners Investment Advisory’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	18,279 +2,753	+18%	+$201K	0.01%	1141
2026 Q1	$1.12M	Buy	15,526 +15,313	+7,189%	+$872K	0.01%	1111
2025 Q4	$9.01K	Hold	213	–	–	﹤0.01%	3484
2025 Q3	$12.1K	Buy	213 +211	+10,550%	+$6.98K	﹤0.01%	3322
2025 Q2	$52	Sell	2 -1	-33%	-$11	﹤0.01%	4062
2025 Q1	$27	Hold	3	–	–	﹤0.01%	3981
2024 Q4	$37	Hold	3	–	–	﹤0.01%	3938
2024 Q3	$52	Hold	3	–	–	﹤0.01%	3689
2024 Q2	$50	Sell	3 -10	-77%	-$211	﹤0.01%	3572
2024 Q1	$187	Hold	13	–	–	﹤0.01%	3476
2023 Q4	$113	Hold	13	–	–	﹤0.01%	3435
2023 Q3	$119	Hold	13	–	–	﹤0.01%	3316
2023 Q2	$115	Hold	13	–	–	﹤0.01%	3263
2023 Q1	$141	Hold	13	–	–	﹤0.01%	3243
2022 Q4	$452	Hold	13	–	–	﹤0.01%	3205
2022 Q3	$1K	Buy	+13	New	+$773	﹤0.01%	3143
2022 Q2	–	Sell	-129	Closed	-$10K	–	3325
2022 Q1	$10K	Hold	129	–	–	﹤0.01%	2667
2021 Q4	$26K	Hold	129	–	–	﹤0.01%	2214
2021 Q3	$35K	Sell	129 -33	-20%	-$7.93K	﹤0.01%	2054
2021 Q2	$42K	Buy	+162	New	+$44.8K	﹤0.01%	3686
2020 Q1	–	Sell	-40	Closed	-$12K	–	2629
2019 Q4	$12K	Hold	40	–	–	﹤0.01%	1955
2019 Q3	$10K	Buy	+40	New	+$14.7K	﹤0.01%	1995

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's NKTR Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Nektar Therapeutics (NKTR) stake by 18% in Q2 2026, buying an estimated $201K and bringing the position to 18,279 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #1141.

Steward Partners Investment Advisory first reported a position in NKTR in Q3 2019 and has held it in 22 quarters since. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

Steward Partners Investment Advisory held 18,279 shares of Nektar Therapeutics worth $1.28M as of Q2 2026.
Steward Partners Investment Advisory bought 2,753 Nektar Therapeutics shares in Q2 2026, an estimated $201K.
Nektar Therapeutics made up 0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1141 holding.
Steward Partners Investment Advisory first reported a position in Nektar Therapeutics in Q3 2019 and has held it in 22 quarters since.
239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.